BK virus maintains a latent infection that is ubiquitous in humans. It has a propensity for
reactivation in the setting of a dysfunctional cellular immune response and is frequently …

Use of immune checkpoint inhibitors (ICIs) in solid organ transplant recipients (SOTRs) with
advanced skin cancers presents a significant clinical management dilemma. SOTRs and …

A hydrogel-based wound dressing with desirable properties is necessary for achieving
functional skin integrity post-injury. This study focuses on preparing a hydrogel using …

In solid organ transplantation, donor-derived cell-free DNA (dd-cfDNA) is a promising
universal noninvasive biomarker for allograft health, where high levels of dd-cfDNA indicate …

Background. Targeting interleukin-6 (IL-6) was shown to counteract donor-specific antibody
production and antibody-mediated rejection (AMR) activity. It is not known whether, or to …

Background. Donor-derived cell-free DNA (dd-cfDNA%) is a biomarker of early acute lung
allograft dysfunction (ALAD), with a value of≥ 1.0% indicating injury. Whether dd-cfDNA% is …

Circulating cell-free DNA (cf-DNA) is released from dead and/or apoptotic leukocytes and
due to neutrophil extracellular traps contributing to an inflammatory response. Previous …

The second half of the previous century witnessed a tremendous rise in the number of
clinical kidney transplants worldwide. This activity was, however, accompanied by many …

Kidney transplantation is the treatment of choice for patients with end-stage renal disease.
Although an improvement in graft survival has been observed in the last decades with the …

The Histocompatibility and Identity Testing Committee offers an overview of the College of
American Pathologists'(CAP) Proficiency Testing (PT) program, commemorating its …